Proximity Proteome Analysis Reveals Novel TREM2 Interactors in the ER-Mitochondria Interface of Human Microglia

Insights

Triggering receptor expressed on myeloid cells 2 (TREM2) is crucial in Alzheimer's disease (AD). New research reveals TREM2 interacts with proteins at Mitochondria-ER contact sites, impacting microglial function and AD pathology.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Triggering receptor expressed on myeloid cells 2 (TREM2) is vital for microglial function and Alzheimer's disease (AD) pathogenesis.
  • Understanding TREM2's cellular interactors beyond DAP12 is crucial for elucidating its role in AD.

Approach:

  • Utilized proximity labeling with TurboID to map protein-protein interactions of TREM2 in live mammalian cells.
  • Investigated TREM2 interactome in human induced pluripotent stem cell-derived microglia.

Key Points:

  • Identified novel TREM2-proximal proteins, including those at Mitochondria-ER contact sites (MERCs).
  • Discovered TREM2 deficiency alters MERC thickness, a key metabolic structural parameter in microglia.
  • Suggests novel roles for TREM2 in the structural plasticity of MERCs.

Conclusions:

  • TREM2 is involved in regulating MERC structure and function.
  • Dysregulation of MERC-related TREM2 functions may contribute to Alzheimer's disease pathobiology.
  • This study provides new insights into TREM2's multifaceted role in cellular physiology and neurodegeneration.